PON1 and cardiovascular disorder: Lavie et al. [103] have reported higher serum levels of lipid peroxidation products and lower PON-1 levels in OSAS patients with and without cardiovascular disease compared with controls (79.5 ± 13.6 versus 86.7 ± 17.6 versus 92.1 ± 14.4 U·min/mL, resp., P = 0.002).